OncLive | Anti-PD-1 Antibody Pidilizumab Shows Promise in Diffuse Large B-Cell Lymphoma OncLive “We think that the approach of disabling immune tolerance at a time when the immune system is remodeling, that is, after stem cell transplantation, is novel and affords an opportunity to enhance remission after stem cell transplant for large cell ... |
